Gram-Negative Endogenous Endophthalmitis: A Systematic Review.
Giorgio TieccoDavide LaurendaAlice MulèStefania ArsuffiSamuele StortiManuela MiglioratiAlessandro BoldiniLiana SignoriniFrancesco CastelliEugenia Quiros-RoldanPublished in: Microorganisms (2022)
Background : Gram-negative bacteria are causative agents of endogenous endophthalmitis (EBE). We aim to systematically review the current literature to assess the aetiologies, risk factors, and early ocular lesions in cases of Gram-negative EBE. Methods : All peer-reviewed articles between January 2002 and August 2022 regarding Gram-negative EBE were included. We conducted a literature search on PubMed and Cochrane Controlled Trials. Results : A total of 115 studies and 591 patients were included, prevalently Asian (98; 81.7%) and male (302; 62.9%). The most common comorbidity was diabetes (231; 55%). The main aetiologies were Klebsiella pneumoniae (510; 66.1%), Pseudomonas aeruginosa (111; 14.4%), and Escherichia coli (60; 7.8%). Liver abscesses (266; 54.5%) were the predominant source of infection. The most frequent ocular lesions were vitreal opacity (134; 49.6%) and hypopyon (95; 35.2%). Ceftriaxone (76; 30.9%), fluoroquinolones (14; 14.4%), and ceftazidime (213; 78.0%) were the most widely used as systemic, topical, and intravitreal anti-Gram-negative agents, respectively. The most reported surgical approaches were vitrectomy (130; 24.1%) and evisceration/exenteration (60; 11.1%). Frequently, visual acuity at discharge was no light perception (301; 55.2%). Conclusions : Gram-negative EBEs are associated with poor outcomes. Our systematic review is mainly based on case reports and case series with significant heterogeneity. The main strength is the large sample spanning over 20 years. Our findings underscore the importance of considering ocular involvement in Gram-negative infections.
Keyphrases
- gram negative
- multidrug resistant
- klebsiella pneumoniae
- systematic review
- acinetobacter baumannii
- escherichia coli
- drug resistant
- pseudomonas aeruginosa
- risk factors
- end stage renal disease
- type diabetes
- cardiovascular disease
- chronic kidney disease
- diabetic retinopathy
- cystic fibrosis
- newly diagnosed
- ejection fraction
- meta analyses
- staphylococcus aureus
- prognostic factors
- randomized controlled trial
- peritoneal dialysis
- adipose tissue
- case control